Press release
Demand for Antibody Testing Market is forecasted to reach a value of US$ 18.89 billion by 2034
The antibody testing market is estimated to be valued at US$ 9.17 billion in 2024. The global demand for antibody testing products is projected to grow at a compound annual growth rate (CAGR) of 7.5%, reaching a market value of US$ 18.89 billion by the end of 2034.Market Dynamics:
The antibody testing market is propelled by several key dynamics. Firstly, the rising incidence of infectious diseases, including COVID-19, HIV/AIDS, and hepatitis, has underscored the importance of efficient diagnostic tools for timely disease detection and management. Additionally, advancements in biotechnology have facilitated the development of innovative antibody testing platforms with enhanced sensitivity and specificity, fostering market expansion. Moreover, the growing demand for point-of-care testing (POCT) solutions and the increasing adoption of antibody testing in research and clinical settings further contribute to market growth.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9194
Market Future Outlook:
The future outlook of the antibody testing market appears promising, with sustained growth anticipated in the coming years. Factors such as the continuous emergence of novel infectious diseases, the growing emphasis on personalized medicine, and the expanding applications of antibody testing in drug development are expected to drive market expansion. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) technologies into antibody testing platforms is poised to enhance diagnostic accuracy and efficiency, thereby bolstering market prospects. Additionally, the rising investments in healthcare infrastructure and the increasing healthcare expenditure in developing regions are likely to create lucrative opportunities for market players.
List of Key Companies Profiled in The Report
Thermos Fisher Scientific
Abbott Laboratories
Bio-Rad Laboratories, Inc.
F. Hoffmann La Roche
Beckton
Agilent Technologies
Dickinson and Company
DiaSorin
Trinity Biotech
Abcam
Zeus Scientific
Market Insights:
The antibody testing market encompasses various segments based on technology, application, end-user, and region. Enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow assays are among the widely adopted technologies for antibody testing. These tests find extensive applications in infectious disease diagnosis, autoimmune disease screening, oncology, and blood screening, among others. Hospitals and clinics, diagnostic laboratories, academic and research institutions, and pharmaceutical and biotechnology companies constitute the primary end-users of antibody testing products and services. Geographically, North America holds a significant share in the antibody testing market, attributed to the presence of well-established healthcare infrastructure, high healthcare expenditure, and the rapid adoption of advanced diagnostic technologies. However, the Asia-Pacific region is poised to witness substantial growth owing to the increasing disease burden, improving healthcare accessibility, and burgeoning investments in healthcare infrastructure.
Want Full Report? Enquire Here- https://www.factmr.com/report/antibody-testing-market
Recent Developments:
Suppliers of antibody testing products are embracing advanced technologies to innovate new equipment aimed at achieving more precise results. Additionally, industry players are committing resources to research and development endeavors to drive innovation, uphold product quality standards, optimize supply chain management systems, and foster collaborations.
For example, in July 2020, Cancer Research UK and Abcam Plc. joined forces to produce and market novel custom antibodies, showcasing the industry's commitment to collaborative efforts in advancing antibody testing capabilities.
Explore More Related Studies Published by Fact.MR Research:
Antibody Contract Manufacturing Market: https://www.factmr.com/report/antibody-contract-manufacturing-market
Antibody Drug Conjugates Contract Market: https://www.factmr.com/report/antibody-drug-conjugates-contract-market
Antibody Fragments Market: https://www.factmr.com/report/antibody-fragments-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Demand for Antibody Testing Market is forecasted to reach a value of US$ 18.89 billion by 2034 here
News-ID: 3376535 • Views: …
More Releases from Fact.MR
![Robot Arms Market is Anticipated to Reach US$ 77.2 Billion by 2033](https://cdn.open-pr.com/L/7/L719764180_g.jpg)
Robot Arms Market is Anticipated to Reach US$ 77.2 Billion by 2033
According to Fact.MR, a market research and competitive intelligence provider, the global robot arms market is estimated to be valued at USD 26.2 billion in 2023 and is expected to expand at an impressive CAGR of 11.4% during the forecast period.
The use of robot arms is increasing across diverse industries such as manufacturing, healthcare, logistics, supply chain, and retail. With the growing integration of technologies like machine learning and artificial…
![Mechanically Separated Poultry Market Is Projected To A Colossal $255.9 Million By 2034](https://cdn.open-pr.com/L/7/L719375357_g.jpg)
Mechanically Separated Poultry Market Is Projected To A Colossal $255.9 Million …
It is anticipated that the global mechanically separated poultry market would reach US$ 160.4 million by 2024. By the end of 2034, the mechanically separated poultry market is expected to grow at a 4.8% CAGR and be worth US$ 255.9 million worldwide. The mechanically separated poultry (MSP) market has seen consistent growth over recent years, driven by increasing demand for cost-effective meat products and advancements in food processing technologies. This…
![Glucose Management Supplement Market Is Expected To A Colossal $17.5 Billion By 2034](https://cdn.open-pr.com/L/7/L719976390_g.jpg)
Glucose Management Supplement Market Is Expected To A Colossal $17.5 Billion By …
The estimated worth of the global glucose management supplement market is expected to rise from US$ 9.7 billion in 2024 to US$ 17.5 billion by the end of 2034. It is true.Sales of glucose management supplements are expected to increase at a compound annual growth rate (CAGR) of 6.1% between 2024 and 2034, according to MR's most recent analysis.
The glucose management supplement market has seen significant growth in recent years,…
![Rosehip Market Is Expanding Estimated To A Colossal $486.7 Million By 2034](https://cdn.open-pr.com/L/7/L719457051_g.jpg)
Rosehip Market Is Expanding Estimated To A Colossal $486.7 Million By 2034
The revenue from the global rosehip market is expected to grow at a 5.6% CAGR from 2024 to 2034, from a value of US$ 282.6 million in 2024 to US$ 486.7 million by the end of that year. The Rosaceae family includes the herbal medicine made from rosehips. This wild rose variety, also called Rosa canina, grows well in many parts of Asia, Africa, and Europe. After fertilization, rosehips, the…
More Releases for Antibody
Antibody Engineering Services Market Size, Share | Industry Report, 2021-2027| F …
Complete study of the global Antibody Engineering Services market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Antibody Engineering Services industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They…
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.
Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515
Monoclonal Antibody Custom Service Market – Overview
It is estimated that monoclonal antibody custom service market is expected to…
Global In-depth analysis and Growth of Market Study on Combination Antibody Ther …
"Global Market Study on Combination Antibody Therapy: Antibody/Antibody Combination Segment Expected to Dominate the Global Market Through 2024" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
. …
Procalcitonin Antibody Market
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E.coli
Scope of the Report:
This report focuses on the Procalcitonin…
Cancer Antibody Drug Conjugates Market Cancer Antibody Drug Conjugates Clinical …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Impetus of Antibody Drug Conjugates
1.1 Prologue to Cancer Antibody Drug Conjugate
1.2 The ABCs of ADCs
Structural Entities of Antibody Drug Conjugate
2.1 Rational Design of Antibody Drug Conjugates
2.1.1 Monoclonal Antibody
2.1.2 Linker
2.1.3 Drug Payload
2.2 Aspects of Conjugational Chemistry
Revolutionizing Antibody Drug Conjugates Generation
…